Amkor Beats Q1, Analysts Raise Targets; Capex and Margin Worries Persist

What happened

Amkor reported better-than-expected Q1 earnings, prompting analysts to boost their forecasts. However, the DeepValue master report maintains a WAIT rating, citing elevated 2026 capex of $2.5B–$3.0B and guided Q1 gross margin of 12.5%–13.5%, which signals ongoing utilization pressure. The Q1 beat does little to alleviate the fundamental risk that construction-heavy spending will depress returns until HDFO AI programs ramp in 2H26. The upcoming May Investor Day must provide concrete customer-backed commitments and a clear path to margin recovery for the thesis to improve. Until then, the stock's valuation at ~30x trailing earnings offers no margin of safety against potential demand or execution missteps.

Implication

The Q1 beat is a modest positive but does not change the core thesis: Amkor's heavy 2026 capex without firm customer commitments and declining gross margins (12.5–13.5% vs. 16.7% in Q4) leave no room for error. Investors should wait for the May Investor Day to see if management provides a credible plan for HDFO ramps and margin normalization, and for Q2 results to confirm utilization improvement. Without those catalysts, the risk of capital impairment outweighs the potential reward.

Thesis delta

The Q1 beat shows near-term operational strength, but the DeepValue thesis remains cautious: margins are under pressure from high capex and under-absorption, and the HDFO AI ramp is still unproven. No fundamental shift in the WAIT rating; the key hinges on May's Investor Day and subsequent margin trajectory.